| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 1,863,298 | 1,848,442 | 1,667,517 | 1,900,433 | | Cost of Revenue | 1,709,304 | 1,685,457 | 1,565,159 | 1,712,340 | | | Gross Profit | 153,994 | 162,985 | 102,358 | 188,093 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 86,539 | 78,633 | 70,405 | 73,106 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 67,455 | 84,352 | 31,953 | 114,987 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (36,772) | (29,678) | 33,883 | (159,996) | | Earnings Before Interest And Taxes | 30,683 | 54,674 | 67,379 | (46,552) | | Interest Expense | 9,627 | 40,401 | 11,960 | 11,607 | | Income Before Tax | 21,056 | 14,273 | 55,419 | (58,159) | | Income Tax Expense | 5,055 | 6,845 | 22,678 | (22,698) | | Minority Interest | (4,160) | (4,381) | (2,332) | (5,860) | | | | Net Income From Continuing Ops | 10,679 | 7,898 | 36,335 | (39,917) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,679 | 7,898 | 36,335 | (39,917) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,679 | $7,898 | $36,335 | ($39,917) |
|
0.50% Nasdaq 
Income Statement
